Drug Profile
Research programme: anti-infectives - JADO Technologies
Alternative Names: J 21601; J 280SLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator JADO Technologies
- Class
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections; Influenza virus infections; Tuberculosis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in HIV-infections in Germany
- 16 Jul 2016 No recent reports of development identified for preclinical development in Influenza-virus-infections in Germany
- 16 Jul 2016 No recent reports of development identified for preclinical development in Tuberculosis in Germany